X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs SUVEN LIFE - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES SUVEN LIFE PIRAMAL ENTERPRISES/
SUVEN LIFE
 
P/E (TTM) x 36.7 19.2 190.9% View Chart
P/BV x 3.1 3.6 85.6% View Chart
Dividend Yield % 0.8 1.1 75.9%  

Financials

 PIRAMAL ENTERPRISES   SUVEN LIFE
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-17
SUVEN LIFE
Mar-16
PIRAMAL ENTERPRISES/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs2,095339 618.9%   
Low Rs1,025144 709.8%   
Sales per share (Unadj.) Rs492.839.2 1,255.7%  
Earnings per share (Unadj.) Rs72.67.5 972.4%  
Cash flow per share (Unadj.) Rs94.78.8 1,078.9%  
Dividends per share (Unadj.) Rs21.002.00 1,050.0%  
Dividend yield (eoy) %1.30.8 162.5%  
Book value per share (Unadj.) Rs862.549.0 1,760.2%  
Shares outstanding (eoy) m172.56127.28 135.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.26.2 51.5%   
Avg P/E ratio x21.532.4 66.4%  
P/CF ratio (eoy) x16.527.5 59.9%  
Price / Book Value ratio x1.84.9 36.7%  
Dividend payout %28.926.8 108.0%   
Avg Mkt Cap Rs m269,19430,732 875.9%   
No. of employees `0004.01.0 420.6%   
Total wages/salary Rs m17,939416 4,308.0%   
Avg. sales/employee Rs Th21,190.35,236.1 404.7%   
Avg. wages/employee Rs Th4,470.1436.5 1,024.1%   
Avg. net profit/employee Rs Th3,120.0995.5 313.4%   
INCOME DATA
Net Sales Rs m85,0374,995 1,702.4%  
Other income Rs m2,338194 1,208.0%   
Total revenues Rs m87,3745,189 1,683.9%   
Gross profit Rs m34,9911,233 2,838.8%  
Depreciation Rs m3,817167 2,282.9%   
Interest Rs m20,31054 37,472.0%   
Profit before tax Rs m13,2021,205 1,095.9%   
Minority Interest Rs m1,6990-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1000-   
Tax Rs m2,281255 894.6%   
Profit after tax Rs m12,520950 1,318.4%  
Gross profit margin %41.124.7 166.8%  
Effective tax rate %17.321.2 81.6%   
Net profit margin %14.719.0 77.4%  
BALANCE SHEET DATA
Current assets Rs m87,5904,986 1,756.7%   
Current liabilities Rs m185,5781,042 17,806.1%   
Net working cap to sales %-115.279.0 -146.0%  
Current ratio x0.54.8 9.9%  
Inventory Days Days3161 50.9%  
Debtors Days Days4839 121.5%  
Net fixed assets Rs m108,5233,126 3,472.2%   
Share capital Rs m345127 271.1%   
"Free" reserves Rs m148,4813,717 3,994.2%   
Net worth Rs m148,8266,236 2,386.4%   
Long term debt Rs m144,957432 33,531.6%   
Total assets Rs m482,3948,079 5,970.8%  
Interest coverage x1.723.2 7.1%   
Debt to equity ratio x1.00.1 1,405.1%  
Sales to assets ratio x0.20.6 28.5%   
Return on assets %6.812.4 54.8%  
Return on equity %8.415.2 55.2%  
Return on capital %12.018.9 63.3%  
Exports to sales %087.5 0.0%   
Imports to sales %012.2 0.0%   
Exports (fob) Rs mNA4,371 0.0%   
Imports (cif) Rs mNA611 0.0%   
Fx inflow Rs m15,0014,666 321.5%   
Fx outflow Rs m5,150942 546.6%   
Net fx Rs m9,8513,724 264.5%   
CASH FLOW
From Operations Rs m-100,393922 -10,888.6%  
From Investments Rs m-24,202-619 3,908.0%  
From Financial Activity Rs m135,705-698 -19,430.8%  
Net Cashflow Rs m11,110-396 -2,807.6%  

Share Holding

Indian Promoters % 52.9 63.4 83.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 0.0 -  
FIIs % 26.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 36.5 45.2%  
Shareholders   93,274 37,287 250.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   STERLING BIOTECH  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Mr Modi Providing Impetus to Defense Industry and Key Stocks in Action Today(Pre-Open)

Addressing the Uttar Pradesh Investors Summit, Mr. Modi announced the creation of a defense industrial corridor in Bundelkhand.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Feb 21, 2018 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS